Medindia
Advertisement

Positive Results of the Chinese bird flu vaccine

by Savitha C Muppala on September 8, 2006 at 8:54 AM

Positive Results of the Chinese bird flu vaccine
Sinovac Biotech, a reputed name in the pharmaceutical Industry in China has placed on record the successful initial phase of the H5N1 bird flu vaccine . The vaccine is said to operate in low doses, nearly one-third to two-thirds lower than the dosage used in the trials undertaken till date. The smaller doses are proven to be more effective.

During the trials it was observed that just two 10-microgram doses of the Sinovac vaccine, in combination with alum, gave immunity to nearly 65% of the people, six weeks after the commencement of the clinical trails.
Advertisement

The Chinese results are extremely positive which means within six months of round the clock working by the manufacturing companies, sufficient vaccine will be produced to cater to 742 million people, which will help in tiding over a potential pandemic.

Source: Medindia
SAV
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
'Hybrid Immunity' may Help Elude COVID-19 Pandemic
Stroop Effect
Plant-Based Diet may Reduce the Risk of COVID-19
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Bird Flu Flu Swine Flu 
Recommended Reading
Bird Flu
Bird flu (avian influenza/avian flu) is a disease caused by an influenza virus (H5N1) that primarily...
Swine Flu
Swine flu, a type of influenza caused by a new strain of the H1N1 Type A influenza virus has origina...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use